Erythema Multiforme
Erythema Multiforme
Erythema Multiforme
MULTIFORME
CONTENTS
1-INTRODUCTION
2-ETIOLOGY AND PATHOGENESIS
3-CLINICAL FINDINGS
4-ORAL MANIFESTATIONS
5-DIFFERENTIAL DIAGNOSIS
6-LABORATORY FINDINGS
7-MANAGEMENT
INTRODUCTION
Erythema multiforme (EM) is an acute, self-limited, inflammatory
mucocutaneous disease that manifests on the skin and often oral mucosa,
although other mucosal surfaces, such as the genitalia, may also be involved.
It represents a hypersensitivity reaction to infectious agents (majority of cases)
or medications.
It is classified as -
EM minor if there is less than 10% of skin involvement and there is minimal to
no mucous membrane involvement.
EM major has more extensive skin involvement, with the oral mucosa and other
mucous membranes.
However, there is likely a subset of EM that affects the oral mucosa only without
skin involvement. Fulminant forms of erythema multiforme labeled Stevens-
Johnson syndrome (SJS) and toxic epidermal necrolysis. However, more recent
studies suggest that EM is etiopathogenetically distinct from those two latter
conditions .
ETIOLOGY AND PATHOGENESIS
• HSV gingivostomatitis with its viral features and erosions and ulcerations may
resemble oral EM, but these lesions culture positive for HSV and do not usually
present with the typical skin rash. Oral ulcers of HSV are usually smaller, well
circumscribed, and clustered, whereas EM lesions are larger and irregular.
Autoimmune vesiculobullous disease such as pemphigus and pemphigoid may
have oral ulcers and skin lesions, although skin lesions are bullous in nature and
not maculopapular.
• Hemorrhagic crusts on the lips are seen in paraneoplastic pemphigus (associated
with malignancies) and Stevens Johnson syndrome. The latter may be difficult to
distinguish from EM.
LABORATORY FINDINGS
• The diagnosis is made mainly on clinical findings and a recent history of HSV
infection.
• IgG and IgM levels not a reliable test although they may be suggestive. A negative
IgG level rules out HSV as an etiologic agent.
• Early lesions show lymphocytes and histiocytes in the superficial dermis around
superficial dermal vessels.
MANAGEMENT
• Mild oral EM can be managed with systemic or topical analgesics for pain and supportive care
since the disease is self- limiting and resolves within a few weeks.
• More severe cases are usually managed with systemic corticosteroids although patients often
worsen on discontinuation of steroid therapy.. Topical steroids may also help solve lesions. If
suspected of being HSV-associated should be treated with anti- viral medications, and
prophylaxis may prevent recurrences.. Treatment with acyclovir at the first sign of disease in
recurrent EM controls disease in approximately half of patients. Other treatment modalities
include dapsone, hydroxychloroquine, azathioprine, methotrexate, and intravenous
immunoglobulin.
• Continuous acyclovir at 400 mg twice a day prevents development of EM in most patients with
hSV-related EM, whereas EM not related to HSV responded well to azathioprine (100-150
mg/day).
REFERENCES-